Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granocyte 34 Prophylaxis for Neutropenia in Taxotere-Treated Solid Tumours
NCT01107756Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2010
- Primary completion
- Jul 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of granulocyte colony-stimulating factor (G-CSF) in neutropenia, sponsored by Sanofi. Started Mar 2010; status: completed.
02
Drugs
granulocyte colony-stimulating factor (G-CSF)
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01107756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107756.